4,507 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Semanteon Capital Management LP

Semanteon Capital Management LP purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,507 shares of the biotechnology company’s stock, valued at approximately $1,164,000.

Several other hedge funds also recently added to or reduced their stakes in the stock. Westfield Capital Management Co. LP lifted its position in Axon Enterprise by 184.3% in the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after acquiring an additional 451,350 shares during the last quarter. Vaughan Nelson Investment Management L.P. boosted its position in shares of Axon Enterprise by 18.4% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock valued at $27,019,000 after purchasing an additional 16,230 shares during the period. BKM Wealth Management LLC purchased a new position in Axon Enterprise during the 4th quarter worth approximately $32,000. Sumitomo Mitsui Trust Holdings Inc. increased its position in Axon Enterprise by 0.3% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock worth $29,320,000 after buying an additional 495 shares during the period. Finally, International Assets Investment Management LLC purchased a new stake in Axon Enterprise in the fourth quarter valued at approximately $39,907,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

AXON stock traded up $3.83 on Thursday, reaching $306.24. 305,890 shares of the company’s stock were exchanged, compared to its average volume of 469,582. The stock has a fifty day moving average of $302.78 and a 200-day moving average of $260.58. The firm has a market cap of $23.11 billion, a PE ratio of 133.15 and a beta of 0.93. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The company had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. As a group, equities analysts predict that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. StockNews.com cut shares of Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. Robert W. Baird upped their target price on shares of Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. Barclays increased their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research note on Thursday, February 29th. JPMorgan Chase & Co. boosted their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Finally, William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Wednesday. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $312.64.

Get Our Latest Report on Axon Enterprise

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.